FIRST TRUST ALERIAN DISRUPTIVE TECHNOLOGY REAL ESTATE ETF DTRE 深 沪
等待开盘 05-13 09:30:00 美东时间
42.7666
-0.247
-0.57%
华盛通- 最 高42.79
- 今 开42.79
- 成交量 736股
- 最 低 42.7666
- 昨 收 43.0132
- 总市值 1674.77万
- 52周最高 43.4477
- 市盈率 静 --
- 换手率 0.19%
- 52周最低 37.5359
- 委 比 0.00%
- 总股本 39.16万
- 历史最高 49.7796
- 量 比 1.89
- 振 幅 0.05%
- 历史最低 16.5735
- 每 手 1
- 风险率 1.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sumitomo Rubber to Supply Dunlop Grandtrek PT20 as Factory Tire for Subaru Outback US Model
Sumitomo Rubber to Supply Dunlop Grandtrek PT20 as Factory Tire for Subaru Outback US Model Dunlop, a Sumitomo Rubber brand, began supplying GRANDTREK PT20 tires as factory-standard fitment for Subaru’s all-new Outback (U.S. model), which launched in the U.S. in April 2025. The factory-standard tire
03-10 13:02
BRIEF-LTIMindtree Collaborates With Nvidia To Support Central Board Of Direct Taxes
BRIEF-LTIMindtree Collaborates With Nvidia To Support Central Board Of Direct Taxes Feb 26 (Reuters) - LTIMindtree Ltd LTIM.NS : LTIMINDTREE - COLLABORATES WITH NVIDIA TO SUPPORT CENTRAL BOARD OF DIRECT TAXES Source text: ID:nBSEbLfPl3 Further company coverage: LTIM.NS (( Reuters.Briefs@thomsonreute
02-26 13:30
BRIEF-Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Dec 3 (Reuters) - Windtree Therapeutics Inc WINT.PK: WINDTREE THERAPEUTICS ANNOUNCES IT HAS SIGNED A LETTER OF INTENT TO ACQUIRE COMMLOAN, INC. A REVENUE GENERATING COMPANY IN THE RAPIDLY GROWING FINT...
2025-12-03 22:03
BRIEF-Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Windtree Therapeutics Inc WINT.PK: WINDTREE THERAPEUTICS ANNOUNCES IT MAY RECEIVE LICENSE AGREEMENT PAYMENTS FROM ITS LICENSEE FOR RENEWED ACUTE PULMONARY DEVELOPMENT BY THE LICENSEE WINDTREE THERAPEU...
2025-11-17 22:09
BRIEF-Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Sept 2 (Reuters) - Windtree Therapeutics Inc WINT.PK: WINDTREE THERAPEUTICS STOCKHOLDERS APPROVE KEY PROPOSALS FOR REVENUE AND PROFIT GENERATION AT THE SPECIAL STOCKHOLDER MEETING Source text: ID:nGNX...
2025-09-03 00:52
BRIEF-Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study
Aug 5 (Reuters) - Windtree Therapeutics Inc WINT.O: WINDTREE THERAPEUTICS INC - ANNOUNCES INTERIM ANALYSIS OF ISTAROXIME PHASE 2 STUDY - SEC FILING WINDTREE THERAPEUTICS INC - ISTAROXIME ADDED TO INOT...
2025-08-05 21:50
BRIEF-Kraken And Windtree Therapeutics Announce Strategic Partnership For BNB Custody, Trading, And OTC Services
July 22 (Reuters) - Windtree Therapeutics Inc WINT.O: KRAKEN AND WINDTREE THERAPEUTICS ANNOUNCE STRATEGIC PARTNERSHIP FOR BNB CUSTODY, TRADING, AND OTC SERVICES WINDTREE THERAPEUTICS INC - TERM SHEET ...
2025-07-22 21:15
BRIEF-Windtree Therapeutics Enters Note Purchase Agreements On June 27, 2025
July 3 (Reuters) - Windtree Therapeutics Inc WINT.O: WINDTREE THERAPEUTICS INC - ENTERS NOTE PURCHASE AGREEMENTS ON JUNE 27, 2025 - SEC FILING ((Reuters.Briefs@thomsonreuters.com;))
2025-07-04 03:17
BRIEF-Windtree Announces Issuance Of Istaroxime Patent For The United States For Acute Heart Failure
July 2 (Reuters) - Windtree Therapeutics Inc WINT.O: WINDTREE ANNOUNCES ISSUANCE OF ISTAROXIME PATENT FOR THE UNITED STATES FOR ACUTE HEART FAILURE WINDTREE THERAPEUTICS INC - ISTAROXIME PATENT PROVID...
2025-07-02 21:05
BRIEF-Windtree Advances Lower Cost Manufacturing Of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel
June 26 (Reuters) - Windtree Therapeutics Inc WINT.O: WINDTREE ADVANCES LOWER COST MANUFACTURING OF PHEXXI, EVOFEM’S HORMONE-FREE, ON-DEMAND PRESCRIPTION CONTRACEPTIVE GEL WINDTREE THERAPEUTICS: CONTR...
2025-06-27 05:15
